NeoGenomics, Inc. Increase (Decrease) in Contract with Customer, Liability
NeoGenomics, Inc. (NEO) reported Increase (Decrease) in Contract with Customer, Liability of $1.50 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-11-04
- NeoGenomics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-09-30 was $900.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month |
|---|---|---|---|
| 2021-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.50M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $600.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |